Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross-over pharmacokinetic drug-drug interaction study.

IF 20.1 1区医学 Q1 ONCOLOGY

Cancer Communications Pub Date : 2025-05-01 DOI:10.1002/cac2.70030

Niels Heersche, Daan A C Lanser, Esther Oomen-de Hoop, Attila Içli, Peter de Bruijn, Marthe S Paats, Elisabeth F C van Rossum, Stijn L W Koolen, Ron H N van Schaik, Anne-Marie C Dingemans, G D Marijn Veerman, Ron H J Mathijssen

引用次数: 0

查看原文本刊更多论文

西马鲁肽损害阿勒替尼的生物利用度：一项基于交叉药代动力学药物相互作用研究的警告。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer Communications Biochemistry, Genetics and Molecular Biology-Cancer Research

CiteScore

25.50

自引率

4.30%

发文量

153

审稿时长

4 weeks

期刊介绍： Cancer Communications is an open access, peer-reviewed online journal that encompasses basic, clinical, and translational cancer research. The journal welcomes submissions concerning clinical trials, epidemiology, molecular and cellular biology, and genetics.